Trials

University Hospitals Birmingham NHS Foundation Trust is a regional and national centre for specialist clinical services.

It is home to some of the country’s leading clinical research institutions, and is dedicated to developing and implementing groundbreaking treatments, technologies and techniques.

  • A Phase 3b Multicenter Openlabel PCI32765 (Ibrutinib) Longterm Extension Study

    View Trial
  • TSB-STRATFix

    STRATFix: Enabling stratified medicine with novel fixatives for improved pre-analytical pathology workflows

    View Trial
  • Generation of high affinity T cell receptors directed against human tumour associated antigens

    View Trial
  • IciCLLe

    Assessment of the Mechanism of Action of Ibrutinib (PCI-32765) in B-cell Receptor Pathway Inhibition in CLL

    View Trial
  • Imaging Capture Study

    Imaging Capture Study

    View Trial
  • Clinico-pathological correlations of acute thrombotic microangiopathy in transplant renal biopsies

    View Trial
  • SUMIT

    A Randomised DoubleBlind Study to Assess the Efficacy of Selumetinib (AZD6244 HydSulfate) in Combination with Dacarbazine Compared with Placebo in Combination with Dacarbazine as First Systemic Therapy in Patients with Metastatic Uveal Melanoma (SUMIT)

    View Trial
  • B-cell Immune Responses to Pneumococcal Vaccination in HIV-infected patients

    View Trial
  • SCOT

    A study of adjuvant chemotherapy in colorectal cancer by the CaCTUS and OCTO groups (SCOT)

    View Trial
  • A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn’s Disease

    View Trial